MedTrace Logo

Erector Spinae vs. PENG Block for Total Hip Arthroplasty

NCT06083428 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2024-06-18

No results posted yet for this study

Summary

Effect of PENG block and ESPB on pain management, and NLR and PLR following knee arthroplasty

Conditions

  • Hip Arthropathy
  • Hip Osteoarthritis
  • Hip Pain Chronic

Interventions

DRUG

Ropivacaine 0.2% Injectable Solution Erector Spinae Plane Block

ultrasound guided ESPB - L4 level, unilateral

DRUG

Ropivacaine 0.2% Injectable Solution - PENG block

ultrasound guided PENG block

DRUG

Control Test

Only spinal anesthesia

Sponsors & Collaborators

  • Poznan University of Medical Sciences

    lead OTHER

Principal Investigators

  • Małgorzata Domagalska, Ph.D. · Poznań University of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-17
Primary Completion
2024-06-11
Completion
2024-06-11

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06083428 on ClinicalTrials.gov